Elekta AB (publ) (OTCMKTS:EKTAY) Sees Significant Decrease in Short Interest

Elekta AB (publ) (OTCMKTS:EKTAY) was the recipient of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 500 shares, a decrease of 76.2% from the June 15th total of 2,100 shares. Based on an average daily volume of 39,400 shares, the short-interest ratio is presently 0.0 days.

Elekta AB (publ) Stock Down 1.4 %

EKTAY stock traded down $0.09 during trading on Friday, reaching $6.32. 8,067 shares of the stock were exchanged, compared to its average volume of 10,084. The firm’s 50 day moving average is $6.95 and its 200 day moving average is $7.26. The company has a quick ratio of 0.76, a current ratio of 1.00 and a debt-to-equity ratio of 0.45. Elekta AB has a twelve month low of $6.04 and a twelve month high of $8.62.

Elekta AB (publ) (OTCMKTS:EKTAY) last released its quarterly earnings data on Wednesday, June 5th. The company reported $0.11 EPS for the quarter. Elekta AB (publ) had a return on equity of 13.27% and a net margin of 7.19%. The firm had revenue of $475.78 million during the quarter. Equities analysts expect that Elekta AB will post 0.4 EPS for the current fiscal year.

Elekta AB (publ) Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.